•
Jun 30, 2024

Option Care Health Q2 2024 Earnings Report

Option Care Health's financial performance remained resilient amidst a difficult environment, with a focus on providing unparalleled care and delivering hope to patients and their families.

Key Takeaways

Option Care Health reported net revenue of $1,227.2 million, a 14.8% increase compared to the second quarter of 2023. Net income was $53.0 million, or $0.30 diluted earnings per share. Adjusted EBITDA was $108.4 million, and cash flow from operations was $195.7 million.

Net revenue increased by 14.8% to $1,227.2 million compared to Q2 2023.

Gross profit was $249.4 million, representing 20.3% of net revenue.

Net income decreased to $53.0 million, or $0.30 diluted earnings per share.

Cash flow from operations increased to $195.7 million compared to Q2 2023.

Total Revenue
$1.23B
Previous year: $1.07B
+14.8%
EPS
$0.3
Previous year: $0.63
-52.4%
Adjusted EBITDA
$108M
Previous year: $110M
-1.5%
Cash Flow from Operations
$196M
Previous year: $170M
+15.5%
Gross Profit
$249M
Previous year: $251M
-0.6%
Cash and Equivalents
$377M
Previous year: $441M
-14.6%
Free Cash Flow
$186M
Previous year: $162M
+14.9%
Total Assets
$3.35B
Previous year: $3.32B
+0.8%

Option Care Health

Option Care Health

Forward Guidance

For the full year 2024, Option Care Health expects to generate net revenue of $4.75 billion to $4.85 billion and adjusted EBITDA of $435 million to $450 million.

Positive Outlook

  • Net revenue of $4.75 billion to $4.85 billion
  • Adjusted EBITDA of $435 million to $450 million
  • Cash flow from operations of at least $300 million, consistent with previous guidance
  • Effective tax rate of 26% - 28%, consistent with previous guidance
  • Net interest expense of approximately $55 million to $60 million, consistent with previous guidance